Digital Health and Big Data for Drug Development

Wednesday, November 7, 2018 - 3:00pm - 3:30pm
Lind 305
Ray Liu (Takeda Pharmaceuticals Inc.)
Novel digital technology allows study subjects to be assessed with new metrics, monitored remotely and continuously, and deep phenotyped to reveal new patterns. Coupled with Big Data, digital technology has great potential to make the drug more efficient and fulfill the promise of personalized medicine. The presentation is introductory in nature to help researchers understand the status of digital technology implementation in clinical trials. Challenges and opportunities for analytical development will also be discussed.